Medpace Holdings, Inc. Deferred Tax Assets, Deferred Income
Medpace Holdings, Inc. (MEDP) had Deferred Tax Assets, Deferred Income of $15.01 million as of 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsDeferredIncome · last filed 2026-02-10
- 2025-12-31: Deferred Tax Assets, Deferred Income $15.01M.
- 2024-12-31: Deferred Tax Assets, Deferred Income $127.11M.
- 2023-12-31: Deferred Tax Assets, Deferred Income $98.44M.
- 2022-12-31: Deferred Tax Assets, Deferred Income $67.79M.
| Period end | Deferred Tax Assets, Deferred Income |
|---|---|
| 2025-12-31 | $15.01M 10-K · filed 2026-02-10 |
| 2024-12-31 | $127.11M 10-K · filed 2026-02-10 |
| 2023-12-31 | $98.44M 10-K · filed 2025-02-11 |
| 2022-12-31 | $67.79M 10-K · filed 2024-02-13 |
| 2021-12-31 | $37.23M 10-K · filed 2023-02-14 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |